 |
|
|
| |
Safety, PK, and Efficacy of Low-Dose B/F/TAF
in Children ≥2 Years Old Living With HIV
|
| |
| |
CROI 2020 March 8-11
Reported by Jules Levin
Carina A. Rodriguez,1 Kulkanya Chokephaibulkit,2 Afaaf Liberty,3 Renate Strehlau,4 Riana van Zyl,4 Pope Kosalaraksa,5 Coleen K. Cunningham,4
Eric J. McGrath,6 Natella Rakhmanina,7 Heather Maxwell,8 Danielle Porter,8 Sophia R. Majeed,8 Shaolan S. Xiang,8 Diana M. Brainard,8 Cheryl Pikora8
1University of South Florida, Tampa, FL; 2Mahidol University, Nakhon Pathom, Thailand; 3Chris Hani Baragwanath Hospital, Johannesburg, South Africa; 4Rahima Moosa Mother and Child Hospital, University of the Witwatersrand Faculty of Health Sciences,
Johannesburg; 5Khon Kaen University, Khon Kaen, Thailand; 6Children’s Hospital of Michigan, Detroit; 7The Children’s Research Institute, Children’s National Hospital, Washington, DC; 8Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
